{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:50:10Z","timestamp":1791298210744,"version":"4.1.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T00:00:00Z","timestamp":1307664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T00:00:00Z","timestamp":1307664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1038\/leu.2011.143","type":"journal-article","created":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T08:49:05Z","timestamp":1307695745000},"page":"1665-1673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["The controversial role of the Hedgehog pathway in normal and malignant hematopoiesis"],"prefix":"10.1038","volume":"25","author":[{"given":"B G","family":"Mar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Amakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Aifantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Buonamici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,10]]},"reference":[{"key":"BFleu2011143_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/287795a0","volume":"287","author":"C Nusslein-Volhard","year":"1980","unstructured":"Nusslein-Volhard C, Wieschaus E . Mutations affecting segment number and polarity in Drosophila. Nature 1980; 287: 795\u2013801.","journal-title":"Nature"},{"key":"BFleu2011143_CR2","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1101\/gad.938601","volume":"15","author":"PW Ingham","year":"2001","unstructured":"Ingham PW, McMahon AP . Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001; 15: 3059\u20133087.","journal-title":"Genes Dev"},{"key":"BFleu2011143_CR3","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature03994","volume":"437","author":"S Ahn","year":"2005","unstructured":"Ahn S, Joyner AL . In vivo analysis of quiescent adult neural stem cells responding to Sonic hedgehog. Nature 2005; 437: 894\u2013897.","journal-title":"Nature"},{"key":"BFleu2011143_CR4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature03100","volume":"432","author":"PA Beachy","year":"2004","unstructured":"Beachy PA, Karhadkar SS, Berman DM . Tissue repair and stem cell renewal in carcinogenesis. Nature 2004; 432: 324\u2013331.","journal-title":"Nature"},{"key":"BFleu2011143_CR5","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1073\/pnas.0812110106","volume":"106","author":"Y Wang","year":"2009","unstructured":"Wang Y, Zhou Z, Walsh CT, McMahon AP . Selective translocation of intracellular Smoothened to the primary cilium in response to Hedgehog pathway modulation. Proc Natl Acad Sci USA 2009; 106: 2623\u20132628.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011143_CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1083\/jcb.200907126","volume":"187","author":"L Milenkovic","year":"2009","unstructured":"Milenkovic L, Scott MP, Rohatgi R . Lateral transport of Smoothened from the plasma membrane to the membrane of the cilium. J Cell Biol 2009; 187: 365\u2013374.","journal-title":"J Cell Biol"},{"key":"BFleu2011143_CR7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nature00989","volume":"418","author":"J Taipale","year":"2002","unstructured":"Taipale J, Cooper MK, Maiti T, Beachy PA . Patched acts catalytically to suppress the activity of Smoothened. Nature 2002; 418: 892\u2013897.","journal-title":"Nature"},{"key":"BFleu2011143_CR8","doi-asserted-by":"crossref","first-page":"8408","DOI":"10.1073\/pnas.0602852103","volume":"103","author":"RB Corcoran","year":"2006","unstructured":"Corcoran RB, Scott MP . Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells. Proc Natl Acad Sci USA 2006; 103: 8408\u20138413.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011143_CR9","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1074\/jbc.M611741200","volume":"282","author":"JR Dwyer","year":"2007","unstructured":"Dwyer JR, Sever N, Carlson M, Nelson SF, Beachy PA, Parhami F . Oxysterols are novel activators of the hedgehog signaling pathway in pluripotent mesenchymal cells. J Biol Chem 2007; 282: 8959\u20138968.","journal-title":"J Biol Chem"},{"key":"BFleu2011143_CR10","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1242\/dev.124.13.2537","volume":"124","author":"J Lee","year":"1997","unstructured":"Lee J, Platt KA, Censullo P, Ruiz i Altaba A . Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. Development 1997; 124: 2537\u20132552.","journal-title":"Development"},{"key":"BFleu2011143_CR11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.0022-202X.2004.22612.x","volume":"122","author":"MS Ikram","year":"2004","unstructured":"Ikram MS, Neill GW, Regl G, Eichberger T, Frischauf AM, Aberger F et al. GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter. J Invest Dermatol 2004; 122: 1503\u20131509.","journal-title":"J Invest Dermatol"},{"key":"BFleu2011143_CR12","first-page":"181","volume":"1805","author":"S Teglund","year":"2010","unstructured":"Teglund S, Toftgard R . Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim Biophys Acta 2010; 1805: 181\u2013208.","journal-title":"Biochim Biophys Acta"},{"key":"BFleu2011143_CR13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.30","volume":"20","author":"Y Lim","year":"2010","unstructured":"Lim Y, Matsui W . Hedgehog signaling in hematopoiesis. Crit Rev Eukaryot Gene Expr 2010; 20: 129\u2013139.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"BFleu2011143_CR14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0925-4773(97)00664-3","volume":"62","author":"SM Farrington","year":"1997","unstructured":"Farrington SM, Belaoussoff M, Baron MH . Winged-helix, Hedgehog and Bmp genes are differentially expressed in distinct cell layers of the murine yolk sac. Mech Dev 1997; 62: 197\u2013211.","journal-title":"Mech Dev"},{"key":"BFleu2011143_CR15","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1242\/dev.128.10.1717","volume":"128","author":"MA Dyer","year":"2001","unstructured":"Dyer MA, Farrington SM, Mohn D, Munday JR, Baron MH . Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. Development 2001; 128: 1717\u20131730.","journal-title":"Development"},{"key":"BFleu2011143_CR16","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1101\/gad.13.16.2072","volume":"13","author":"B St-Jacques","year":"1999","unstructured":"St-Jacques B, Hammerschmidt M, McMahon AP . Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 1999; 13: 2072\u20132086.","journal-title":"Genes Dev"},{"key":"BFleu2011143_CR17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0092-8674(01)00385-3","volume":"106","author":"XM Zhang","year":"2001","unstructured":"Zhang XM, Ramalho-Santos M, McMahon AP . Smoothened mutants reveal redundant roles for Shh and Ihh signaling including regulation of L\/R symmetry by the mouse node. Cell 2001; 106: 781\u2013792.","journal-title":"Cell"},{"key":"BFleu2011143_CR18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1242\/dev.129.2.361","volume":"129","author":"N Byrd","year":"2002","unstructured":"Byrd N, Becker S, Maye P, Narasimhaiah R, St-Jacques B, Zhang X et al. Hedgehog is required for murine yolk sac angiogenesis. Development 2002; 129: 361\u2013372.","journal-title":"Development"},{"key":"BFleu2011143_CR19","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1242\/dev.004432","volume":"134","author":"J Astorga","year":"2007","unstructured":"Astorga J, Carlsson P . Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4. Development 2007; 134: 3753\u20133761.","journal-title":"Development"},{"key":"BFleu2011143_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bcmd.2009.04.004","volume":"43","author":"SO Cridland","year":"2009","unstructured":"Cridland SO, Keys JR, Papathanasiou P, Perkins AC . Indian hedgehog supports definitive erythropoiesis. Blood Cells Mol Dis 2009; 43: 149\u2013155.","journal-title":"Blood Cells Mol Dis"},{"key":"BFleu2011143_CR21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0092-8674(00)80165-8","volume":"86","author":"A Medvinsky","year":"1996","unstructured":"Medvinsky A, Dzierzak E . Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 1996; 86: 897\u2013906.","journal-title":"Cell"},{"key":"BFleu2011143_CR22","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1242\/dev.034728","volume":"136","author":"M Peeters","year":"2009","unstructured":"Peeters M, Ottersbach K, Bollerot K, Orelio C, de Bruijn M, Wijgerde M et al. Ventral embryonic tissues and Hedgehog proteins induce early AGM hematopoietic stem cell development. Development 2009; 136: 2613\u20132621.","journal-title":"Development"},{"key":"BFleu2011143_CR23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.devcel.2005.01.010","volume":"8","author":"M Gering","year":"2005","unstructured":"Gering M, Patient R . Hedgehog signaling is required for adult blood stem cell formation in zebrafish embryos. Dev Cell 2005; 8: 389\u2013400.","journal-title":"Dev Cell"},{"key":"BFleu2011143_CR24","doi-asserted-by":"crossref","first-page":"14134","DOI":"10.1073\/pnas.0604568103","volume":"103","author":"JJ Trowbridge","year":"2006","unstructured":"Trowbridge JJ, Scott MP, Bhatia M . Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. Proc Natl Acad Sci USA 2006; 103: 14134\u201314139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011143_CR25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","volume":"14","author":"C Dierks","year":"2008","unstructured":"Dierks C, Beigi R, Guo GR, Zirlik K, Stegert MR, Manley P et al. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 2008; 14: 238\u2013249.","journal-title":"Cancer Cell"},{"key":"BFleu2011143_CR26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","volume":"458","author":"C Zhao","year":"2009","unstructured":"Zhao C, Chen A, Jamieson CH, Fereshteh M, Abrahamsson A, Blum J et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009; 458: 776\u2013779.","journal-title":"Nature"},{"key":"BFleu2011143_CR27","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2009-09-241703","volume":"115","author":"A Merchant","year":"2010","unstructured":"Merchant A, Joseph G, Wang Q, Brennan S, Matsui W . Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors. Blood 2010; 115: 2391\u20132396.","journal-title":"Blood"},{"key":"BFleu2011143_CR28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/84282","volume":"2","author":"G Bhardwaj","year":"2001","unstructured":"Bhardwaj G, Murdoch B, Wu D, Baker DP, Williams KP, Chadwick K et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001; 2: 172\u2013180.","journal-title":"Nat Immunol"},{"key":"BFleu2011143_CR29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.stem.2009.03.015","volume":"4","author":"J Gao","year":"2009","unstructured":"Gao J, Graves S, Koch U, Liu S, Jankovic V, Buonamici S et al. Hedgehog signaling is dispensable for adult hematopoietic stem cell function. Cell Stem Cell 2009; 4: 548\u2013558.","journal-title":"Cell Stem Cell"},{"key":"BFleu2011143_CR30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.stem.2009.03.016","volume":"4","author":"I Hofmann","year":"2009","unstructured":"Hofmann I, Stover EH, Cullen DE, Mao J, Morgan KJ, Lee BH et al. Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell 2009; 4: 559\u2013567.","journal-title":"Cell Stem Cell"},{"key":"BFleu2011143_CR31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.3563490","volume":"236","author":"KW Kinzler","year":"1987","unstructured":"Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O\u2019Brien SJ et al. Identification of an amplified, highly expressed gene in a human glioma. Science 1987; 236: 70\u201373.","journal-title":"Science"},{"key":"BFleu2011143_CR32","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0092-8674(00)81268-4","volume":"85","author":"H Hahn","year":"1996","unstructured":"Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996; 85: 841\u2013851.","journal-title":"Cell"},{"key":"BFleu2011143_CR33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/34201","volume":"391","author":"J Xie","year":"1998","unstructured":"Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 1998; 391: 90\u201392.","journal-title":"Nature"},{"key":"BFleu2011143_CR34","first-page":"2085","volume":"57","author":"T Pietsch","year":"1997","unstructured":"Pietsch T, Waha A, Koch A, Kraus J, Albrecht S, Tonn J et al. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 1997; 57: 2085\u20132088.","journal-title":"Cancer Res"},{"key":"BFleu2011143_CR35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/emmm.200900039","volume":"1","author":"F Varnat","year":"2009","unstructured":"Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P et al. Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 2009; 1: 338\u2013351.","journal-title":"EMBO Mol Med"},{"key":"BFleu2011143_CR36","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/leu.2010.35","volume":"24","author":"RR Singh","year":"2010","unstructured":"Singh RR, Kim JE, Davuluri Y, Drakos E, Cho-Vega JH, Amin HM et al. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia 2010; 24: 1025\u20131036.","journal-title":"Leukemia"},{"key":"BFleu2011143_CR37","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01972","volume":"425","author":"DM Berman","year":"2003","unstructured":"Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003; 425: 846\u2013851.","journal-title":"Nature"},{"key":"BFleu2011143_CR38","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature02962","volume":"431","author":"SS Karhadkar","year":"2004","unstructured":"Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004; 431: 707\u2013712.","journal-title":"Nature"},{"key":"BFleu2011143_CR39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cub.2006.11.033","volume":"17","author":"V Clement","year":"2007","unstructured":"Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A . HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007; 17: 165\u2013172.","journal-title":"Curr Biol"},{"key":"BFleu2011143_CR40","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1634\/stemcells.2007-0166","volume":"25","author":"EE Bar","year":"2007","unstructured":"Bar EE, Chaudhry A, Lin A, Fan X, Schreck K, Matsui W et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells 2007; 25: 2524\u20132533.","journal-title":"Stem Cells"},{"key":"BFleu2011143_CR41","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1158\/0008-5472.CAN-09-0756","volume":"69","author":"JW Theunissen","year":"2009","unstructured":"Theunissen JW, de Sauvage FJ . Paracrine Hedgehog signaling in cancer. Cancer Res 2009; 69: 6007\u20136010.","journal-title":"Cancer Res"},{"key":"BFleu2011143_CR42","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature07275","volume":"455","author":"RL Yauch","year":"2008","unstructured":"Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP et al. A paracrine requirement for hedgehog signalling in cancer. Nature 2008; 455: 406\u2013410.","journal-title":"Nature"},{"key":"BFleu2011143_CR43","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1073\/pnas.0813203106","volume":"106","author":"H Tian","year":"2009","unstructured":"Tian H, Callahan CA, DuPree KJ, Darbonne WC, Ahn CP, Scales SJ et al. Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc Natl Acad Sci USA 2009; 106: 4254\u20134259.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011143_CR44","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1073\/pnas.0611682104","volume":"104","author":"CD Peacock","year":"2007","unstructured":"Peacock CD, Wang Q, Gesell GS, Corcoran-Schwartz IM, Jones E, Kim J et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA 2007; 104: 4048\u20134053.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011143_CR45","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm1614","volume":"13","author":"C Dierks","year":"2007","unstructured":"Dierks C, Grbic J, Zirlik K, Beigi R, Englund NP, Guo GR et al. Essential role of stromally induced hedgehog signaling in B-cell malignancies. Nat Med 2007; 13: 944\u2013951.","journal-title":"Nat Med"},{"key":"BFleu2011143_CR46","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-08-1808","volume":"69","author":"RR Singh","year":"2009","unstructured":"Singh RR, Cho-Vega JH, Davuluri Y, Ma S, Kasbidi F, Milito C et al. Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma. Cancer Res 2009; 69: 2550\u20132558.","journal-title":"Cancer Res"},{"key":"BFleu2011143_CR47","doi-asserted-by":"crossref","first-page":"e15262","DOI":"10.1371\/journal.pone.0015262","volume":"5","author":"TL Lin","year":"2010","unstructured":"Lin TL, Wang QH, Brown P, Peacock C, Merchant AA, Brennan S et al. Self-renewal of acute lymphocytic leukemia cells is limited by the hedgehog pathway inhibitors cyclopamine and IPI-926. PLoS One 2010; 5: e15262.","journal-title":"PLoS One"},{"key":"BFleu2011143_CR48","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"CL Sawyers","year":"1999","unstructured":"Sawyers CL . Chronic myeloid leukemia. N Engl J Med 1999; 340: 1330\u20131340.","journal-title":"N Engl J Med"},{"key":"BFleu2011143_CR49","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD . Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290\u2013293.","journal-title":"Nature"},{"key":"BFleu2011143_CR50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/306277a0","volume":"306","author":"CR Bartram","year":"1983","unstructured":"Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D et al. Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1983; 306: 277\u2013280.","journal-title":"Nature"},{"key":"BFleu2011143_CR51","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1158\/0008-5472.CAN-03-3656","volume":"64","author":"P Ramaraj","year":"2004","unstructured":"Ramaraj P, Singh H, Niu N, Chu S, Holtz M, Yee JK et al. Effect of mutational inactivation of tyrosine kinase activity on BCR\/ABL-induced abnormalities in cell growth and adhesion in human hematopoietic progenitors. Cancer Res 2004; 64: 5322\u20135331.","journal-title":"Cancer Res"},{"key":"BFleu2011143_CR52","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood.V97.8.2406","volume":"97","author":"RC Zhao","year":"2001","unstructured":"Zhao RC, Jiang Y, Verfaillie CM . A model of human p210(bcr\/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR\/ABL-containing retroviral vector. Blood 2001; 97: 2406\u20132412.","journal-title":"Blood"},{"key":"BFleu2011143_CR53","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408\u20132417.","journal-title":"N Engl J Med"},{"key":"BFleu2011143_CR54","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","volume":"348","author":"SG O\u2019Brien","year":"2003","unstructured":"O\u2019Brien SG, Guilhot F, Larson RA, Gathmann I, Baccarani M, Cervantes F et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003; 348: 994\u20131004.","journal-title":"N Engl J Med"},{"key":"BFleu2011143_CR55","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/leu.2009.38","volume":"23","author":"A Hochhaus","year":"2009","unstructured":"Hochhaus A, O\u2019Brien SG, Guilhot F, Druker BJ, Branford S, Foroni L et al. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia 2009; 23: 1054\u20131061.","journal-title":"Leukemia"},{"key":"BFleu2011143_CR56","first-page":"162","volume":"91","author":"M Colombat","year":"2006","unstructured":"Colombat M, Fort MP, Chollet C, Marit G, Roche C, Preudhomme C et al. Molecular remission in chronic myeloid leukemia patients with sustained complete cytogenetic remission after imatinib mesylate treatment. Haematologica 2006; 91: 162\u2013168.","journal-title":"Haematologica"},{"key":"BFleu2011143_CR57","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","volume":"11","author":"FX Mahon","year":"2010","unstructured":"Mahon FX, Rea D, Guilhot J, Guilhot F, Huguet F, Nicolini F et al. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol 2010; 11: 1029\u20131035.","journal-title":"Lancet Oncol"},{"key":"BFleu2011143_CR58","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0002-9343(77)90124-3","volume":"63","author":"PJ Fialkow","year":"1977","unstructured":"Fialkow PJ, Jacobson RJ, Papayannopoulou T . Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte\/macrophage. Am J Med 1977; 63: 125\u2013130.","journal-title":"Am J Med"},{"key":"BFleu2011143_CR59","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.142.3597.1305","volume":"142","author":"RH Levin","year":"1963","unstructured":"Levin RH, Whang J, Tjio JH, Carbone PP, Frei III E, Freireich EJ . Persistent mitosis of transfused homologous leukocytes in children receiving antileukemic therapy. Science 1963; 142: 1305\u20131311.","journal-title":"Science"},{"key":"BFleu2011143_CR60","first-page":"338","volume":"2","author":"RG Graw Jr","year":"1970","unstructured":"Graw Jr RG, Buckner CD, Whang-Peng J, Leventhal BG, Kruger G, Berard C et al. Complication of bone-marrow transplantation. Graft-versus-host disease resulting from chronic-myelogenous-leukaemia leucocyte transfusions. Lancet 1970; 2: 338\u2013341.","journal-title":"Lancet"},{"key":"BFleu2011143_CR61","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood.V87.4.1539.bloodjournal8741539","volume":"87","author":"C Sirard","year":"1996","unstructured":"Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B et al. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. Blood 1996; 87: 1539\u20131548.","journal-title":"Blood"},{"key":"BFleu2011143_CR62","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1182\/blood.V91.7.2406","volume":"91","author":"JC Wang","year":"1998","unstructured":"Wang JC, Lapidot T, Cashman JD, Doedens M, Addy L, Sutherland DR et al. High level engraftment of NOD\/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood 1998; 91: 2406\u20132414.","journal-title":"Blood"},{"key":"BFleu2011143_CR63","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","volume":"94","author":"T Holyoake","year":"1999","unstructured":"Holyoake T, Jiang X, Eaves C, Eaves A . Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 1999; 94: 2056\u20132064.","journal-title":"Blood"},{"key":"BFleu2011143_CR64","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/sj.leu.2404318","volume":"20","author":"E Jabbour","year":"2006","unstructured":"Jabbour E, Kantarjian H, Jones D, Talpaz M, Bekele N, O\u2019Brien S et al. Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate. Leukemia 2006; 20: 1767\u20131773.","journal-title":"Leukemia"},{"key":"BFleu2011143_CR65","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00280-003-0741-6","volume":"53","author":"P le Coutre","year":"2004","unstructured":"le Coutre P, Kreuzer KA, Pursche S, Bonin M, Leopold T, Baskaynak G et al. Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588. Cancer Chemother Pharmacol 2004; 53: 313\u2013323.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFleu2011143_CR66","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1182\/blood-2006-07-036012","volume":"109","author":"S Picard","year":"2007","unstructured":"Picard S, Titier K, Etienne G, Teilhet E, Ducint D, Bernard MA et al. Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia. Blood 2007; 109: 3496\u20133499.","journal-title":"Blood"},{"key":"BFleu2011143_CR67","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/jnci\/92.20.1641","volume":"92","author":"C Gambacorti-Passerini","year":"2000","unstructured":"Gambacorti-Passerini C, Barni R, le Coutre P, Zucchetti M, Cabrita G, Cleris L et al. Role of alpha1 acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor STI571. J Natl Cancer Inst 2000; 92: 1641\u20131650.","journal-title":"J Natl Cancer Inst"},{"key":"BFleu2011143_CR68","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood.V99.2.713","volume":"99","author":"HG Jorgensen","year":"2002","unstructured":"Jorgensen HG, Elliott MA, Allan EK, Carr CE, Holyoake TL, Smith KD . Alpha1-acid glycoprotein expressed in the plasma of chronic myeloid leukemia patients does not mediate significant in vitro resistance to STI571. Blood 2002; 99: 713\u2013715.","journal-title":"Blood"},{"key":"BFleu2011143_CR69","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","volume":"96","author":"FX Mahon","year":"2000","unstructured":"Mahon FX, Deininger MW, Schultheis B, Chabrol J, Reiffers J, Goldman JM et al. Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance. Blood 2000; 96: 1070\u20131079.","journal-title":"Blood"},{"key":"BFleu2011143_CR70","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1182\/blood.V101.6.2368","volume":"101","author":"FX Mahon","year":"2003","unstructured":"Mahon FX, Belloc F, Lagarde V, Chollet C, Moreau-Gaudry F, Reiffers J et al. MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models. Blood 2003; 101: 2368\u20132373.","journal-title":"Blood"},{"key":"BFleu2011143_CR71","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2003-12-4276","volume":"104","author":"J Thomas","year":"2004","unstructured":"Thomas J, Wang L, Clark RE, Pirmohamed M . Active transport of imatinib into and out of cells: implications for drug resistance. Blood 2004; 104: 3739\u20133745.","journal-title":"Blood"},{"key":"BFleu2011143_CR72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cancergencyto.2005.01.015","volume":"162","author":"S Galimberti","year":"2005","unstructured":"Galimberti S, Cervetti G, Guerrini F, Testi R, Pacini S, Fazzi R et al. Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment. Cancer Genet Cytogenet 2005; 162: 57\u201362.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFleu2011143_CR73","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2006-02-003145","volume":"108","author":"NE Jordanides","year":"2006","unstructured":"Jordanides NE, Jorgensen HG, Holyoake TL, Mountford JC . Functional ABCG2 is overexpressed on primary CML CD34+ cells and is inhibited by imatinib mesylate. Blood 2006; 108: 1370\u20131373.","journal-title":"Blood"},{"key":"BFleu2011143_CR74","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1182\/blood-2005-02-0694","volume":"106","author":"LC Crossman","year":"2005","unstructured":"Crossman LC, Druker BJ, Deininger MW, Pirmohamed M, Wang L, Clark RE . hOCT 1 and resistance to imatinib. Blood 2005; 106: 1133\u20131134; author reply 1134.","journal-title":"Blood"},{"key":"BFleu2011143_CR75","doi-asserted-by":"crossref","first-page":"e990","DOI":"10.1371\/journal.pone.0000990","volume":"2","author":"NL Komarova","year":"2007","unstructured":"Komarova NL, Wodarz D . Effect of cellular quiescence on the success of targeted CML therapy. PLoS One 2007; 2: e990.","journal-title":"PLoS One"},{"key":"BFleu2011143_CR76","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nature03669","volume":"435","author":"F Michor","year":"2005","unstructured":"Michor F, Hughes TP, Iwasa Y, Branford S, Shah NP, Sawyers CL et al. Dynamics of chronic myeloid leukaemia. Nature 2005; 435: 1267\u20131270.","journal-title":"Nature"},{"key":"BFleu2011143_CR77","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nm1487","volume":"12","author":"I Roeder","year":"2006","unstructured":"Roeder I, Horn M, Glauche I, Hochhaus A, Mueller MC, Loeffler M . Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications. Nat Med 2006; 12: 1181\u20131184.","journal-title":"Nat Med"},{"key":"BFleu2011143_CR78","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/sj.leu.2403724","volume":"19","author":"MS Holtz","year":"2005","unstructured":"Holtz MS, Forman SJ, Bhatia R . Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli. Leukemia 2005; 19: 1034\u20131041.","journal-title":"Leukemia"},{"key":"BFleu2011143_CR79","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"SM Graham","year":"2002","unstructured":"Graham SM, Jorgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 2002; 99: 319\u2013325.","journal-title":"Blood"},{"key":"BFleu2011143_CR80","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/leu.2010.143","volume":"24","author":"Y Chen","year":"2010","unstructured":"Chen Y, Peng C, Sullivan C, Li D, Li S . Critical molecular pathways in cancer stem cells of chronic myeloid leukemia. Leukemia 2010; 24: 1545\u20131554.","journal-title":"Leukemia"},{"key":"BFleu2011143_CR81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/107327480901600204","volume":"16","author":"A Quintas-Cardama","year":"2009","unstructured":"Quintas-Cardama A, Kantarjian HM, Cortes JE . Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia. Cancer Control 2009; 16: 122\u2013131.","journal-title":"Cancer Control"},{"key":"BFleu2011143_CR82","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","volume":"121","author":"AS Corbin","year":"2011","unstructured":"Corbin AS, Agarwal A, Loriaux M, Cortes J, Deininger MW, Druker BJ . Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity. J Clin Invest 2011; 121: 396\u2013409.","journal-title":"J Clin Invest"},{"key":"BFleu2011143_CR83","doi-asserted-by":"crossref","unstructured":"Irvine DA, Zhang B, Allan EK, Holyoake T, Dorsch M, Manley P et al. Combination of hedgehog pathway inhibitor LDE225 and nilotinib eliminates chronic myeloid leukemia stem and progenitor cells. Blood (ASH) 2009; abstract no. 1428.","DOI":"10.1182\/blood.V114.22.1428.1428"},{"key":"BFleu2011143_CR84","doi-asserted-by":"crossref","unstructured":"Zhang B, Irvine DA, Wei Ho Y, Buonamici S, Manley P, Holyoake T et al. Inhibiton of chronic myeloid leukemia stem cells by the combination of the hoedgehog pathway inhibitor LDE225 with nilotinib. Blood (ASH) 2010; abstract no. 514.","DOI":"10.1182\/blood.V116.21.514.514"},{"key":"BFleu2011143_CR85","doi-asserted-by":"crossref","unstructured":"Schairer A, Shih A, Geron I, Reya T, Levin WJ, Arsdale TV et al. Human blast crisis leukemia stem cell inhibition with a novel smoothened antagonist. Blood (ASH) 2010; abstract no. 1223.","DOI":"10.1182\/blood.V116.21.1223.1223"},{"key":"BFleu2011143_CR86","doi-asserted-by":"crossref","unstructured":"Cea M, Cagnetta A, Cirmena G, Garuti A, Rocco I, Palermo C et al. Hedgehog signaling is useful as a novel molecular marker for predicting relapses and resistance during chronic myeloid leukemia treatment. Blood (ASH) 2010; abstract no. 1215.","DOI":"10.1182\/blood.V116.21.1215.1215"},{"key":"BFleu2011143_CR87","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1073\/pnas.0732813100","volume":"100","author":"JA Williams","year":"2003","unstructured":"Williams JA, Guicherit OM, Zaharian BI, Xu Y, Chai L, Wichterle H et al. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc Natl Acad Sci USA 2003; 100: 4616\u20134621.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011143_CR88","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJMoa0905360","volume":"361","author":"DD Von Hoff","year":"2009","unstructured":"Von Hoff DD, LoRusso PM, Rudin CM, Reddy JC, Yauch RL, Tibes R et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009; 361: 1164\u20131172.","journal-title":"N Engl J Med"},{"key":"BFleu2011143_CR89","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa0902903","volume":"361","author":"CM Rudin","year":"2009","unstructured":"Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009; 361: 1173\u20131178.","journal-title":"N Engl J Med"},{"key":"BFleu2011143_CR90","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1179386","volume":"326","author":"RL Yauch","year":"2009","unstructured":"Yauch RL, Dijkgraaf GJ, Alicke B, Januario T, Ahn CP, Holcomb T et al. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 2009; 326: 572\u2013574.","journal-title":"Science"},{"key":"BFleu2011143_CR91","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/ml1000307","volume":"1","author":"S Pan","year":"2010","unstructured":"Pan S, Wu X, Jiang J, Gao W, Wan Y, Cheng D et al. Discovery of NVP-LDE225, a potent and selective smoothened antagonist. ACS Med Chem Lett 2010; 1: 130\u2013134.","journal-title":"ACS Med Chem Lett"},{"key":"BFleu2011143_CR92","unstructured":"Ahnert JR, Baselga J, Tawbi H, Shou Y, Dummer R, Feng W et al. LDE225, a smoothened (SMO) antagonist: phase I safety and pharmacologic results in patients with advance tumors. Ann Oncol (ESMO) 2010; abstract no. 502PD."},{"key":"BFleu2011143_CR93","doi-asserted-by":"crossref","first-page":"51ra70","DOI":"10.1126\/scitranslmed.3001599","volume":"2","author":"S Buonamici","year":"2010","unstructured":"Buonamici S, Williams J, Morrissey M, Wang A, Guo R, Vattay A et al. Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci Transl Med 2010; 2: 51ra70.","journal-title":"Sci Transl Med"},{"key":"BFleu2011143_CR94","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1021\/jm900305z","volume":"52","author":"MR Tremblay","year":"2009","unstructured":"Tremblay MR, Lescarbeau A, Grogan MJ, Tan E, Lin G, Austad BC et al. Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926). J Med Chem 2009; 52: 4400\u20134418.","journal-title":"J Med Chem"},{"key":"BFleu2011143_CR95","doi-asserted-by":"crossref","unstructured":"Rudin CM, Weiss GJ, Chang A, Gettinger S, Miller WH, Eigl B et al. A phase 1 study of IPI-926, an inhibitor of the hedgehog pathway, in patients (PTS) with advance or metastasis solid tumors. Ann Oncol (ESMO) 2010; abstract no. 501PD.","DOI":"10.1200\/jco.2011.29.15_suppl.3014"},{"key":"BFleu2011143_CR96","doi-asserted-by":"crossref","unstructured":"Siu LL, Papadopoulos K, Alberts SR, Kirchoff-Ross R, Vakkalagadda B, Lang L et al. A first-in-human, phase I study of an oral hedgehog (HH) pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumors. J Clin Oncol (ASCO) 2010; abstract no. 2501.","DOI":"10.1200\/jco.2010.28.15_suppl.2501"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2011143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:08:59Z","timestamp":1648735739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2011143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,10]]},"references-count":96,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["BFleu2011143"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.143","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,10]]},"assertion":[{"value":"20 February 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SB and DA are employee of Novartis Institute of BioMedical Research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}